EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Trefoil Factor‐3 Is a Hypoxia‐Triggered Pro‐Tumorigenic Factor in Hepatoblastoma

Luz A Martínez-Pérez, M Ujue Latasa, Iker Uriarte iD, Amaya López-Pascual, Jasmin Elurbide, Pavel Strnad, Sona Frankova, Eva Sticova, Ondrej Fabian, Maria Arechederra, Eva Santamaria, Josepmaria Argemi und 14 weitere

Liver International · 2026-04 · 46 (4)

DOI: 10.1111/liv.70592 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Liver International, online erschienen am 13.03.2026. Verfasst von Luz A Martínez-Pérez und 25 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Ciencias de la Salud, Centro Universitarios de los Altos, Universidad de Guadalajara, Tepatitlán, México. Hauptthemen laut MEDLINE: Hepatoblastoma, Trefoil Factor-3, Liver Neoplasms. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fundación Científica Asociación Española Contra el Cáncer, Ministerio de Ciencia, Innovación y Universidades, Instituto de Salud Carlos III.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background & Aims Hepatoblastoma (HB) is the most common malignant liver tumour in children. Despite improved survival in low‐risk disease, outcomes for advanced or relapsed HB remain poor, emphasising the need for new therapeutic targets. Hypoxia, a hallmark of aggressive tumours, has recently been implicated in HB pathogenesis, but the molecular mechanisms involved are unclear. This study aimed to characterise the hypoxia‐driven transcriptomic landscape of HB and identify key mediators of tumour progression.

Methods

Transcriptomic analyses of HB cell lines cultured under normoxic and hypoxic conditions were combined with bioinformatic interrogation of public HB datasets, immunohistochemistry of human and murine tumours and plasma ELISA assays. Functional roles of trefoil factor 3 (TFF3) were evaluated through overexpression and shRNA‐mediated knockdown in vitro and in a β‐catenin/YAP‐driven mouse model of HB.

Results

Hypoxia induced broad transcriptional reprogramming in HB cells, including significant upregulation of TFF3 , a secreted oncogenic peptide. TFF3 expression was elevated in HB tissues and plasma, and colocalized with hypoxia marker carbonic anhydrase 9 (CA9). TFF3 promoted proliferation, anchorage‐independent growth and cisplatin resistance under both normoxia and hypoxia. Knockdown of murine Tff3 suppressed tumour formation and angiogenesis in vivo. Transcriptomic and molecular analyses revealed that TFF3 sustains C‐MYC expression and modulates mTOR/GSK3β signalling.

Conclusions

TFF3 is a hypoxia‐inducible factor that enhances HB cell proliferation, survival and chemoresistance. Its tumour‐promoting activity through C‐MYC and mTOR pathways identifies TFF3 as a potential therapeutic target and circulating biomarker in hepatoblastoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HepatoblastomaTrefoil Factor-3Liver NeoplasmsAnimalsHumansMiceCell Line, TumorHypoxiaGene Expression Regulation, NeoplasticCell ProliferationGlycogen Synthase Kinase 3 betaSignal Transduction

Stichwörter der Autor:innen

biomarkerscarcinogenesishepatoblastomahypoxiatrefoil factors

Substanzen

Trefoil Factor-3TFF3 protein, humanGlycogen Synthase Kinase 3 beta

Autor:innen und Institutionen

  • Departamento de Ciencias de la Salud, Centro Universitarios de los Altos, Universidad de Guadalajara, Tepatitlán, México.
  • Hepatology Laboratory, Solid Tumors Program, CIMA, CCUN, University of Navarra, Pamplona, Spain.
  • Instituto de Investigaciones Sanitarias de Navarra IdiSNA, Pamplona, Spain.
  • CIBERehd, Madrid, Spain.
  • Medical Clinic III, Gastroenterology, Metabolic Diseases and Intensive Care, University Hospital RWTH Aachen, Aachen, Germany.
  • Department of Hepatogastroenterology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.

ORCID-Profile: Iker Uriarte, Maria L Martinez-Chantar, Jose J G Marin, Carmen Berasain, Matias A Ávila

Förderung

  • Fundación Científica Asociación Española Contra el Cáncer
  • Ministerio de Ciencia, Innovación y Universidades
  • Instituto de Salud Carlos III
  • Junta de Castilla y León
  • Fundació la Marató de TV3
  • Horizon 2020 Framework Programme
  • Agència de Gestió d'Ajuts Universitaris i de Recerca

Zitieren

APA

Martínez-Pérez, L. A., Latasa, M. U., Uriarte, I., López-Pascual, A., Elurbide, J., Strnad, P., Frankova, S., Sticova, E., Fabian, O., Arechederra, M., Santamaria, E., Argemi, J., Sangro, B., Foglia, B., Parola, M., Gutiérrez-Angulo, M., Cairo, S., Bataller, R., Sancho-Bru, P., …, & Ávila, M. A. (2026). Trefoil Factor‐3 Is a Hypoxia‐Triggered Pro‐Tumorigenic Factor in Hepatoblastoma. Liver International, 46(4). https://doi.org/10.1111/liv.70592

Vancouver

Martínez-Pérez LA, Latasa MU, Uriarte I, López-Pascual A, Elurbide J, Strnad P, et al. Trefoil Factor‐3 Is a Hypoxia‐Triggered Pro‐Tumorigenic Factor in Hepatoblastoma. Liver International. 2026;46(4). doi:10.1111/liv.70592

BibTeX
@article{MartnezPrez2026,
  author = {Martínez-Pérez, Luz A and Latasa, M Ujue and Uriarte, Iker and López-Pascual, Amaya and Elurbide, Jasmin and Strnad, Pavel and Frankova, Sona and Sticova, Eva and Fabian, Ondrej and Arechederra, Maria and Santamaria, Eva and Argemi, Josepmaria and Sangro, Bruno and Foglia, Beatrice and Parola, Maurizio and Gutiérrez-Angulo, Melva and Cairo, Stefano and Bataller, Ramón and Sancho-Bru, Pau and Martinez-Chantar, Maria L and Marin, Jose J G and Castaneda, Andrea and Armengol, Carolina and Berasain, Carmen and Fernandez-Barrena, Maite G and Ávila, Matias A},
  title = {Trefoil Factor‐3 Is a Hypoxia‐Triggered Pro‐Tumorigenic Factor in Hepatoblastoma},
  journal = {Liver International},
  year = {2026},
  volume = {46},
  number = {4},
  doi = {10.1111/liv.70592}
}
Kostenlos starten →